Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $607,701 (100.0% shares, 0.0% debt)

Holdings (33)

APLS APELLIS PHARMACEUTICALS INC 15.8%
Value ($000) $95,953 Shares 3,006,980 Est. Cost $47.09 Unrealized -36.1%
AVBP ARRIVENT BIOPHARMA INC 9.0%
Value ($000) $54,862 Shares 2,059,387 Est. Cost $20.73 Unrealized +38.5%
DNTH DIANTHUS THERAPEUTICS INC 7.6%
Value ($000) $46,002 Shares 2,110,167 Est. Cost $20.37 Unrealized +26.2%
CNTA CENTESSA PHARMACEUTICALS PLC 5.5%
Value ($000) $33,384 Shares 1,993,052 Est. Cost $7.34 Unrealized
VERONA PHARMA PLC 4.4%
Value ($000) $26,530 Shares 571,264 Est. Cost $17.59 Unrealized
NUVB NUVATION BIO INC 4.0%
Value ($000) $24,480 Shares 9,202,907 Est. Cost $2.99 Unrealized -14.0%
INSM INSMED INC 3.8%
Value ($000) $22,921 Shares 332,000 Est. Cost $21.76 Unrealized +231.0%
COGT COGENT BIOSCIENCES INC 3.5%
Value ($000) $21,551 Shares 2,763,000 Est. Cost $9.86 Unrealized +1.1%
SRRK SCHOLAR ROCK HLDG CORP 3.5%
Value ($000) $21,091 Shares 488,000 Est. Cost $32.56 Unrealized 0.0%
MIND MEDICINE MINDMED INC 3.5%
Value ($000) $21,005 Shares 3,018,000 Est. Cost $8.34 Unrealized
OCUL OCULAR THERAPEUTIX INC 3.4%
Value ($000) $20,710 Shares 2,425,000 Est. Cost $7.10 Unrealized +37.5%
TSHA TAYSHA GENE THERAPIES INC 3.0%
Value ($000) $18,079 Shares 10,450,000 Est. Cost $2.20 Unrealized -5.7%
INSM INSMED INC 2.8%
Value ($000) $17,260 Shares 250,000 Est. Cost $21.76 Unrealized +231.0%
VRDN VIRIDIAN THERAPEUTICS INC 2.7%
Value ($000) $16,678 Shares 870,000 Est. Cost $22.43 Unrealized -3.1%
GOSS GOSSAMER BIO INC 2.7%
Value ($000) $16,599 Shares 18,350,000 Est. Cost $1.89 Unrealized -54.8%
DYN DYNE THERAPEUTICS INC 2.6%
Value ($000) $15,738 Shares 668,000 Est. Cost $24.32 Unrealized +21.6%
PHVS PHARVARIS N V 2.5%
Value ($000) $14,914 Shares 778,000 Est. Cost $18.74 Unrealized +9.8%
CRBP CORBUS PHARMACEUTICALS HLDGS 2.2%
Value ($000) $13,157 Shares 1,115,000 Est. Cost $40.87 Unrealized -59.0%
MERUS N V 2.1%
Value ($000) $12,951 Shares 308,000 Est. Cost $42.05 Unrealized
ERAS ERASCA INC 2.1%
Value ($000) $12,893 Shares 5,136,795 Est. Cost $2.74 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 2.0%
Value ($000) $12,118 Shares 441,600 Est. Cost $30.51 Unrealized -15.3%
SNDX SYNDAX PHARMACEUTICALS INC 2.0%
Value ($000) $11,951 Shares 904,000 Est. Cost $17.11 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 1.9%
Value ($000) $11,604 Shares 1,370,000 Est. Cost $10.36 Unrealized 0.0%
UNICYCIVE THERAPEUTICS INC 1.3%
Value ($000) $7,942 Shares 10,000,000 Est. Cost $0.46 Unrealized
REGULUS THERAPEUTICS INC 1.3%
Value ($000) $7,661 Shares 4,848,802 Est. Cost $1.76 Unrealized
CATX PERSPECTIVE THERAPEUTICS INC 1.2%
Value ($000) $7,352 Shares 2,304,752 Est. Cost $12.05 Unrealized -32.2%
NGNE NEUROGENE INC 1.1%
Value ($000) $6,927 Shares 303,000 Est. Cost $37.29 Unrealized -0.2%
ALLOVIR INC 0.8%
Value ($000) $4,710 Shares 11,215,000 Est. Cost $0.42 Unrealized
ATYR ATYR PHARMA INC 0.5%
Value ($000) $3,258 Shares 900,000 Est. Cost $3.03 Unrealized 0.0%
BBOT HELIX ACQUISITION CORP II 0.4%
Value ($000) $2,625 Shares 250,000 Est. Cost $10.35 Unrealized +1.5%
CNTA CENTESSA PHARMACEUTICALS PLC 0.4%
Value ($000) $2,546 Shares 152,000 Est. Cost $7.34 Unrealized
MERSANA THERAPEUTICS INC 0.2%
Value ($000) $1,419 Shares 992,000 Est. Cost $4.48 Unrealized
NUVATION BIO INC 0.1%
Value ($000) $831 Shares 312,336 Est. Cost $2.29 Unrealized